Figure 1: Overview of some polypeptide growth factors

GROWTH FACTORS AND WOUND HEALING

The wound-healing process is complex and as yet not fully understood. The area of tissue damage becomes the focus of various events, often beginning with immunological and inflammatory reactions. The various cells involved in such processes, as well as additional cells at the site of the wound, also secrete various growth factors. These mitogens stimulate the growth and activation of various cell types, including fibroblasts (which produce collagen and elastin precursors, and ground substance), epithelial cells (e.g. skin cells) and vascular endothelial cells. Such cells advance healing by promoting processes such as granulation (growth of connective tissue and small blood vessels at the healing surface) and subsequent epithelialization. The growth factors that appear most significant to this process include fibroblast growth factors (FGFs), transforming growth factors (TGFs), platelet-derived growth factor (PDGF), insulin-like growth factor 1 (IGF-1) and epidermal growth factor (EGF).

INSULIN-LIKE GROWTH FACTORS (IGFs)

The insulin-like growth factors (also termed ‘somatomedins’), constitute a family of two closely related (small) polypeptides: insulin-like growth factor 1 (IGF-1) and insulin-like growth factor 2 (IGF-2). As the names suggest, these growth factors bear a strong structural resemblance to insulin (or, more accurately, proinsulin). Infusion of IGF-1 decreases circulating levels of insulin and glucagon, increases tissue glucose uptake and inhibits hepatic glucose export. IGFs display pluripotent activities, regulating the growth, activation, differentiation (and maintenance of the differentiated state) of a wide variety of cell and tissue types (discussed later). The full complexity and variety of their biological activities are only now beginning to be appreciated.

EPIDERMAL GROWTH FACTOR (EGF)

EGF was one of the first growth factors discovered. Its existence was initially noted in the 1960s as a factor present in saliva, which could promote premature tooth eruption and eyelid opening in neonatal mice. It was first purified from urine and named urogastrone, owing to its ability to inhibit the secretion of gastric acid. EGF has subsequently proved to exert a powerful mitogenic effect on many cell types, and its receptor is expressed by most cells. Its influence on endothelial cells, epithelial cells and fibroblasts is particularly noteworthy, and the skin appears to be its major physiological target. It stimulates growth of the epidermal layer. Along with several other growth factors, EGF plays a role in the wound-healing process. EGF is synthesized mainly by monocytes and ectodermal cells, as well as by the kidney and duodenal glands. It is found in most bodily fluids, especially milk.

PLATELET-DERIVED GROWTH FACTOR (PDGF)

Platelet-derived growth factor (PDGF) is a polypeptide growth factor which is sometimes termed ‘osteosarcoma-derived growth factor’ (ODGF) or ‘glioma-derived growth factor’ (GDGF). It was first identified over 20 years ago as being the major growth factor synthesized by platelets. It is also produced by a variety of cell types. PDGF exhibits a mitogenic effect on fibroblasts, smooth muscle cells and glial cells, and exerts various additional biological activities.

FIBROBLAST GROWTH FACTORS (FGFs)

Fibroblast growth factors (FGFs) constitute a family of about 20 proteins (numbered consecutively FGF-1 to FGF-20). Typically, they display a molecular mass in the region of 18– 28 kDa and induce a range of mitogenic, chemotactic and angiogenic responses. FGFs induce the majority of their characteristic responses via binding to high-affinity cell surface receptors. Four such receptors, which show 55-72% homology at the amino acid level, have been identified to date. The receptors are multi-domain, consisting of three extracellular immunoglobulin-like domains (Ig domains), a highly hydrophobic transmembrane domain and two intracellular tyrosine kinase domains. Different receptors are found on different cell types and each receptor is either strongly, moderately, poorly or not activated by its own characteristic range of FGFs. This signalling complexity underscores the complexity of biological responses induced by FGFs.

TRANSFORMING GROWTH FACTORS (TGFs)

Transforming growth factors (TGFs) represent yet another family of polypeptide mitogens. The members of this family include TGF-α, as well as several species of TGF-β.

TGF-α is initially synthesized as an integral membrane protein. Proteolytic cleavage releases the soluble growth factor, which is a 50 amino acid polypeptide. This growth factor exhibits a high amino acid homology with EGF, and it induces its biological effects by binding to the EGF receptor. It is synthesized by various body tissues, as well as by monocytes and keratinocytes. It is also manufactured by many tumour cell types, for which it can act as an autocrine growth factor. TGF-βwas first described as a growth factor capable of inducing transformation of several fibroblast cell lines (hence the name, transforming growth factors). It is now recognized that ‘TGF-β’ actually consists of three separate growth factors: TGF-β1, -β2 and -β3. Although the product of distinct genes, all exhibit close homology. In the mature form, they exist as homodimers, with each subunit containing 112 amino acid residues. Most body cells synthesize TGF-β, singly or in combination.

NEUROTROPHIC FACTORS

Neurotrophic factors constitute a group of cytokines that regulate the development, maintenance and survival of neurons in both the central and peripheral nervous systems. While the first member of this family (nerve growth factor, NGF) was discovered more than 50 years ago, it is only in the last decade that the other members have been identified and characterized. The major sub-family of neurotrophic factors are the neurotrophins. The neurotrophins are a group of neurotrophic factors which all belong to the same gene family. They include NGF, as well as brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin 4/5 (NT-4/5) and neurotrophin-6 (NT-6). All are small, basic proteins sharing approximately 50% amino acid homology. They exist mainly as homodimers and promote signal transduction by binding to a member of the Trk family of tyrosine kinase receptors.

Reference:

Walsh, G. (2013). Biopharmaceuticals: biochemistry and biotechnology. John Wiley & Sons.